In 2017, the MPP continued to play a strong role in improving access to HIV, hepatitis C and tuberculosis treatments for people living in resource-limited settings.
The report selected five HIV and two hepatitis C compounds that, if successfully developed, could improve standard of care for people living in developing countries
The document explains how the MPP works to accelerate access to treatments in low- and middle-income countries
Browse through our latest publications here. You can refine your search using our filtering system on the right hand side.